New Key Statistics Module, Z-Score and F-Score
WAR:BIO Key Ratios
| Market Cap zł M | 240.42 |
| Enterprise Value zł M | 291.85 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.41 |
| Price/Sales | 1.36 |
| Price/Free Cash Flow | 18.13 |
| Price/Owner Earnings | 19.25 |
| Payout Ratio % | -- |
| Revenue (TTM) zł M | 177.00 |
| EPS (TTM) zł | -0.06 |
| Beneish M-Score | -3.08 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -4.10 |
| EV-to-EBIT | 69.49 |
| EV-to-EBITDA | 7.29 |
| PEG | -- |
| Shares Outstanding M | 85.86 |
| Net Margin (%) | -3.27 |
| Operating Margin % | -9.48 |
| Pre-tax Margin (%) | -1.71 |
| Quick Ratio | 0.20 |
| Current Ratio | 1.05 |
| ROA % (ttm) | -0.72 |
| ROE % (ttm) | -0.97 |
| ROIC % (ttm) | -4.28 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.94 |
WAR:BIO Number of Guru Trades
WAR:BIO Volume of Guru Trades
Gurus Latest Trades with WAR:BIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WAR:BIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers